<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.rcuk.ac.uk/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9"><gtr:id>3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9</gtr:id><gtr:name>University of Oxford</gtr:name><gtr:address><gtr:line1>University Chest</gtr:line1><gtr:line2>Wellington Square</gtr:line2><gtr:line4>Oxford</gtr:line4><gtr:postCode>OX1 2JD</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/EDF9EB53-008B-4F75-A492-AC1ADCFE76F0"><gtr:id>EDF9EB53-008B-4F75-A492-AC1ADCFE76F0</gtr:id><gtr:name>Royal Free Hampstead NHS Trust</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/99A20F70-F6B7-43DE-94E4-7004FAE6291E"><gtr:id>99A20F70-F6B7-43DE-94E4-7004FAE6291E</gtr:id><gtr:name>Ludwig Maximilians University Munich</gtr:name><gtr:address><gtr:line1>Geschwister-Scholl-Platz 1</gtr:line1><gtr:postCode>D-80539</gtr:postCode><gtr:region>Unknown</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/318B5D98-4CB4-4B10-A876-08FC93071A56"><gtr:id>318B5D98-4CB4-4B10-A876-08FC93071A56</gtr:id><gtr:name>King's College London</gtr:name><gtr:address><gtr:line1>Capital House</gtr:line1><gtr:line2>2nd Floor, Guys Campus</gtr:line2><gtr:line3>42 Weston Street</gtr:line3><gtr:line4>London</gtr:line4><gtr:postCode>SE1 3QD</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.rcuk.ac.uk:80/organisation/3A5E126D-C175-4730-9B7B-E6D8CF447F83"><gtr:id>3A5E126D-C175-4730-9B7B-E6D8CF447F83</gtr:id><gtr:name>University College London</gtr:name><gtr:department>Institute of Child Health</gtr:department><gtr:address><gtr:line1>Gower Street</gtr:line1><gtr:line4>London</gtr:line4><gtr:postCode>WC1E 6BT</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/3A5E126D-C175-4730-9B7B-E6D8CF447F83"><gtr:id>3A5E126D-C175-4730-9B7B-E6D8CF447F83</gtr:id><gtr:name>University College London</gtr:name><gtr:address><gtr:line1>Gower Street</gtr:line1><gtr:line4>London</gtr:line4><gtr:postCode>WC1E 6BT</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9"><gtr:id>3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9</gtr:id><gtr:name>University of Oxford</gtr:name><gtr:address><gtr:line1>University Chest</gtr:line1><gtr:line2>Wellington Square</gtr:line2><gtr:line4>Oxford</gtr:line4><gtr:postCode>OX1 2JD</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/EDF9EB53-008B-4F75-A492-AC1ADCFE76F0"><gtr:id>EDF9EB53-008B-4F75-A492-AC1ADCFE76F0</gtr:id><gtr:name>Royal Free Hampstead NHS Trust</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/99A20F70-F6B7-43DE-94E4-7004FAE6291E"><gtr:id>99A20F70-F6B7-43DE-94E4-7004FAE6291E</gtr:id><gtr:name>Ludwig Maximilians University Munich</gtr:name><gtr:address><gtr:line1>Geschwister-Scholl-Platz 1</gtr:line1><gtr:postCode>D-80539</gtr:postCode><gtr:region>Unknown</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/318B5D98-4CB4-4B10-A876-08FC93071A56"><gtr:id>318B5D98-4CB4-4B10-A876-08FC93071A56</gtr:id><gtr:name>King's College London</gtr:name><gtr:address><gtr:line1>Capital House</gtr:line1><gtr:line2>2nd Floor, Guys Campus</gtr:line2><gtr:line3>42 Weston Street</gtr:line3><gtr:line4>London</gtr:line4><gtr:postCode>SE1 3QD</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/87FC4C8F-BBB1-4D76-9D6F-183B24B06493"><gtr:id>87FC4C8F-BBB1-4D76-9D6F-183B24B06493</gtr:id><gtr:firstName>David</gtr:firstName><gtr:surname>Long</gtr:surname><gtr:orcidId>0000-0001-6580-3435</gtr:orcidId><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.rcuk.ac.uk:80/projects?ref=MR%2FJ003638%2F1"><gtr:id>236BBCAE-6DD8-4E34-BA6C-000C05F008BA</gtr:id><gtr:title>The role of podocyte thymosin-beta4 in the healthy and diseased glomerulus</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>MR/J003638/1</gtr:grantReference><gtr:abstractText>Long term severe kidney disease can only be treated by dialysis or transplantation, and the number of people needing this type of support has doubled in frequency over the last ten years in the UK. It now affects 100 people per million population and is rising. One key feature of kidney disease is disruption to the filtration unit which is a highly complex structure created from several different cell types. One of these cells, the podocyte, has a highly branched shape which is essential for its function. Disruption to this shape, a feature of many childhood and adult kidney diseases such as minimal change disease and diabetic kidney disease, leads to loss of protein in the urine and if persistent to end stage kidney disease. Therefore, understanding how podocyte shape develops in the first place, could provide the knowledge necessary to restore it after injury and thus greatly improve treatment of many kidney diseases. In this project, I will study the role of a molecule called thymosin-beta4 which is highly expressed in podocytes and involved in maintaining cell shape; key to the development of other organs such as the heart and currently being investigated in clinical trials as a potential treatment for diseases such as wound healing and myocardial infarction. In this New Investigator award, I will look at what thymosin-beta4 does in the developing and mature filtration barrier of the kidney and in an experimental model of kidney disease. If modulation of thymosin-beta4 slows the progression of kidney disease, it could be a new exciting therapeutic avenue for these patients in the future.</gtr:abstractText><gtr:technicalSummary>Research objectives: The objectives of these studies are (i) to determine the role of podocyte thymosin-beta4 in the developing and mature healthy glomerulus using transgenic mice and cultured cells. (ii) determine if modulation of thymosin-beta4 attenuates progression of glomerular disease, hence raising the possibility that thymosin-beta4 could improve the health of kidney patients. (iii) assess the relative contribution of podocytes and other renal sites of thymosin-beta4 in the progression of glomerular disease.

Experimental Design: I will utilise global null-mutants and specific knock down of thymosin-beta4 in the podocyte using floxed thymosin-beta4 animals bred with doxycycline inducible podocyte-specific Cre recombinase mice and will assess changes in the structure and molecular biology of the glomerulus. Moreover, using the above transgenic animals, I will determine whether lack of thymosin-beta4 alters progression of immune-mediated and adriamycin-induced glomerular diseases. These are good models of human pathologies and it will be important to identify how the balance of thymosin-beta4 in different parts of the kidney affects the course of disease because this will influence how targetted therapies need to be developed.

Application and Exploitation: My studies will define the function of thymosin-beta4 in the kidney glomerulus which will lead to high-impact publications in scientific journals. In addition, it could lead to the design of new therapies for human renal disease. If this is the case, then thymosin-beta4 has the potential to impact on society by improving the quality of life of patients with kidney disease as well as a major economic impact by reducing the number on expensive dialysis regimens or needing a kidney transplant.</gtr:technicalSummary><gtr:potentialImpactText>This research has the potential to discover a new treatment strategy for glomerular disease. Glomerular disease, resulting in defective filtration and proteinuria, accounts for many cases of end-stage renal failure (ESRF); a devastating condition requiring life-long dialysis or transplantation. Over the last decade an epidemic of ESRF has occurred, linked to increased obesity and diabetes with a doubling in the UK to 100/million population; costs in the USA have now increased to around $30 billion/annum placing an extremely high burden on healthcare resources. Therefore new therapies preventing glomerular disease are vitally important and have the potential to impact on society by improving the quality of life of patients with kidney disease and have an economic impact by reducing the impact of ESRF and saving healthcare costs. If thymosin-beta4 proves to be a potential therapeutic target in glomerular disease, this will be of potential interest to drug companies. At least one company, Regenerx, has taken thymosin-beta4 into clinical trials for acute myocardial infarction and dermal and ophthalmic wound healing trials (www.regenerx.com), and similar strategies could be used for renal disease.

This New Investigator Award will also contribute to the progression of Dr. Long's own academic career. This will allow me to develop my own group of researchers, facilitating my academic progression through to Lecturer, Senior Lecturer and Professorship over the next 10 years. During the grant, the researcher employed will also be trained in important skills not only in the laboratory, but also academically. This will achieved not only through on-the-job training, but also courses provided for researchers from UCL and ICH. 

Other beneficiaries will include the collaborative team involved in the research both within my Institution and with centres in North America. All of the partners have already contributed reagents or mice along with intellectual input into the design of the grant and their contributions will be key to ensuring the research is successful. Professor Paul Riley (ICH) has a large group working mainly on heart development and has Industry links; Professor Susan Quaggin (Toronto) developed a specific mouse strain and collaborates with researchers around the world to develop new models for important kidney diseases; and Professor Agnes Fogo is a world expert on fibrosis and is at the forefront of designing new technologies to treat patients.

The results of these studies will be of interest to renal researchers as not only we will understand more about thymosin-beta4 in the kidney, but the data will enhance our understanding of the role of this important molecule in kidney development and disease, but may lead to novel insights into the biology of the glomerular filtration barrier. We may also identify potential new functions of thymosin-beta4 and generate new molecular tools which will be of interest to other researchers in other fields, such as vascular biology.</gtr:potentialImpactText><gtr:fund><gtr:end>2015-08-30</gtr:end><gtr:funder url="http://gtr.rcuk.ac.uk:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2012-09-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>483507</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>King's College London (KCL)</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Dr Mike Robson</gtr:description><gtr:id>6621EEFD-EBCE-4349-A7B6-E06BE5F9D058</gtr:id><gtr:impact>Oral and poster presentations at international meetings.</gtr:impact><gtr:partnerContribution>Intellectual input, provision of anti-glomerular basement membrane serum for animal studies.</gtr:partnerContribution><gtr:piContribution>Collaborative studies investigating thymosin-beta 4 in glomerular disease</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2012-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Ludwig Maximilian University of Munich (LMU Munich)</gtr:collaboratingOrganisation><gtr:country>Germany, Federal Republic of</gtr:country><gtr:description>Professor Christian Kupatt</gtr:description><gtr:id>0837157E-E02E-4B25-BD12-D60DBA8F6876</gtr:id><gtr:impact>None to date</gtr:impact><gtr:partnerContribution>Provision of adeno-associated virus for thymosin-beta4</gtr:partnerContribution><gtr:piContribution>Experiments assessing whether adeno-associated virus for thymosin-beta4 improves the progression of glomerular disease.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2016-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Oxford</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Professor Paul Riley</gtr:description><gtr:id>2D8C0BD6-6C3A-4488-BC14-B7BB8859FB32</gtr:id><gtr:impact>Oral and poster presentations at international meetings, generation of podocyte thymosin-beta 4 knock-down mice.</gtr:impact><gtr:partnerContribution>Intellectual input, provision of thymosin-beta 4 knock-out mice.</gtr:partnerContribution><gtr:piContribution>Collaborative studies investigating thymosin-beta 4 in kidney development and disease</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Royal Free Hampstead NHS Trust</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Royal Free Hospital</gtr:department><gtr:description>Professor Alan Salama</gtr:description><gtr:id>DF680436-6E21-4C74-BA60-EE30BB88FC63</gtr:id><gtr:impact>None to date</gtr:impact><gtr:partnerContribution>Provision of human samples from patients with glomerular disease.</gtr:partnerContribution><gtr:piContribution>Assessment of thymosin-beta4 expression in human samples from patients with glomerular disease.</gtr:piContribution><gtr:sector>Hospitals</gtr:sector><gtr:start>2015-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>Kidney Research UK donors visit</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>D604D16F-C4B9-44DD-8CBB-FC6065294E6D</gtr:id><gtr:impact>Around 10 donors from Kidney Research UK attended an afternoon of talks followed up a laboratory tour at the Institute of Child Health.</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Supporters</gtr:primaryAudience><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>UK renal research report launch at the House of Lords</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>B9CF24F6-A3C1-4C2A-892B-DA364B456E91</gtr:id><gtr:impact>I attended the launch of the Kidney Research UK renal research report at the House of Lords - an opportunity to discuss the importance of kidney research with politicians and other policymakers.</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Policymakers/politicians</gtr:primaryAudience><gtr:url>http://www.kidneyresearchuk.org/news/house-of-lords</gtr:url><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Career development session at the 64th Annual Meeting of the British Microcirculation Society</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>29D48AF6-D634-488E-A111-E46A54F1768F</gtr:id><gtr:impact>Part of panel examining scientific career development at the 64th Annual Meeting of the British Microcirculation Society. General discussion and Q and A session with audience members.

Follow-up discussions with audience members regarding career advice</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>keynote/invited speaker</gtr:presentationType><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2014</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Interview with the scientist magazine</gtr:description><gtr:form>A press release, press conference or response to a media enquiry/interview</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>43E54419-4535-46FF-B7C9-6741EC6218C9</gtr:id><gtr:impact>Interview about our study on vascular growth factor therapy for polycystic kidney disease.</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:url>http://www.the-scientist.com/?articles.view/articleNo/43550/title/Rethinking-Lymphatic-Development/</gtr:url><gtr:year>2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Press release for polycystic kidney disease paper</gtr:description><gtr:form>A press release, press conference or response to a media enquiry/interview</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>3B769DC6-851D-461C-A19A-714957E39371</gtr:id><gtr:impact>Numerous press releases from UCL, Great Ormond Street, University of Manchester, Kidney Research UK and Kids Kidney Research describing our work on vascular growth factor therapy for polycystic kidney disease. This was picked up by multiple international news outlets leading to numerous enquires about our work.</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:url>http://www.gosh.nhs.uk/news/latest-press-releases/2015-press-release-archive/researchers-uncover-new-treatment-world-s-most-common-inherited-kidney-disease</gtr:url><gtr:year>2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Interview regarding our study on vascular growth factors in polycystic kidney disease</gtr:description><gtr:form>A press release, press conference or response to a media enquiry/interview</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>300C1743-3694-423B-AFE2-57818A61F64B</gtr:id><gtr:impact>Interview with communications consultant at Kidney Research UK about our work on vascular growth factor therapy in polycystic kidney disease - led to an article in the Journal of Renal Nursing</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:url>http://www.magonlinelibrary.com/doi/abs/10.12968/jorn.2015.7.4.196?journalCode=jorn</gtr:url><gtr:year>2015</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>1600</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Undergraduate Vacation Studentship to Miss Renata Assuncao De Sousa Brites</gtr:description><gtr:end>2015-09-02</gtr:end><gtr:fundingOrg>Physiological Society</gtr:fundingOrg><gtr:id>3C888A22-2A54-4EBA-9AFA-D87838FA1941</gtr:id><gtr:sector>Learned Society</gtr:sector><gtr:start>2015-06-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>200631</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Kidney Research UK Post-doctoral fellowship to Dr Elisavet Vasilopoulou</gtr:description><gtr:end>2018-08-02</gtr:end><gtr:fundingOrg>Kidney Research UK</gtr:fundingOrg><gtr:fundingRef>PDF8/2015</gtr:fundingRef><gtr:id>A992962C-A1D0-4357-BB91-977D54D4C639</gtr:id><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2015-09-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs><gtr:researchMaterialOutput><gtr:description>Mice lacking thymosin-beta4 specifically in the podocyte</gtr:description><gtr:id>CC48FF17-E5AF-4797-8B10-2F8CAAA38C22</gtr:id><gtr:impact>We are currently using this animals to test the role of podocyte thymosin-beta4 in glomerular development and disease.</gtr:impact><gtr:providedToOthers>false</gtr:providedToOthers><gtr:title>Podocyte thymosin-beta4 conditional knock-out mice</gtr:title><gtr:type>Model of mechanisms or symptoms - mammalian in vivo</gtr:type></gtr:researchMaterialOutput></gtr:researchMaterialOutputs><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/4B4EDAB0-0C7D-4706-BEDB-DAFB21EEA87F"><gtr:id>4B4EDAB0-0C7D-4706-BEDB-DAFB21EEA87F</gtr:id><gtr:title>Genetic Background is a Key Determinant of Glomerular Extracellular Matrix Composition and Organization.</gtr:title><gtr:parentPublicationTitle>Journal of the American Society of Nephrology : JASN</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/f04a92eee9b0e7700681cfd7bf95c4ab"><gtr:id>f04a92eee9b0e7700681cfd7bf95c4ab</gtr:id><gtr:otherNames>Randles MJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1046-6673</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/C7DC1AFD-B9AC-4F10-8CE2-2228FD19BEF4"><gtr:id>C7DC1AFD-B9AC-4F10-8CE2-2228FD19BEF4</gtr:id><gtr:title>Heterozygous Vangl2(Looptail) mice reveal novel roles for the planar cell polarity pathway in adult lung homeostasis and repair.</gtr:title><gtr:parentPublicationTitle>Disease models &amp; mechanisms</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/5738a7deaa042805747e3479d67ff814"><gtr:id>5738a7deaa042805747e3479d67ff814</gtr:id><gtr:otherNames>Poobalasingam T</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1754-8403</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/C17DD04A-932D-4ED7-8A05-CEE54A269961"><gtr:id>C17DD04A-932D-4ED7-8A05-CEE54A269961</gtr:id><gtr:title>Aging-associated renal disease in mice is fructokinase dependent.</gtr:title><gtr:parentPublicationTitle>American journal of physiology. Renal physiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/b6dbb379f46741d3fe0d0c5f8a0a7b10"><gtr:id>b6dbb379f46741d3fe0d0c5f8a0a7b10</gtr:id><gtr:otherNames>Roncal-Jimenez CA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1522-1466</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/E3C9DC0A-9E14-4162-BD08-57D616F57573"><gtr:id>E3C9DC0A-9E14-4162-BD08-57D616F57573</gtr:id><gtr:title>Targeted glomerular angiopoietin-1 therapy for early diabetic kidney disease.</gtr:title><gtr:parentPublicationTitle>Journal of the American Society of Nephrology : JASN</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/808513999327fdecf2202b797b820f14"><gtr:id>808513999327fdecf2202b797b820f14</gtr:id><gtr:otherNames>Dessapt-Baradez C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1046-6673</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/F9BE76C5-860B-4BBA-B484-78037797104F"><gtr:id>F9BE76C5-860B-4BBA-B484-78037797104F</gtr:id><gtr:title>Angiogenesis and autosomal dominant polycystic kidney disease.</gtr:title><gtr:parentPublicationTitle>Pediatric nephrology (Berlin, Germany)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/b31418c203091e8945bc50b92174fbda"><gtr:id>b31418c203091e8945bc50b92174fbda</gtr:id><gtr:otherNames>Huang JL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0931-041X</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/B2D82565-E2E8-4DBE-B0A5-2AB3746B18F7"><gtr:id>B2D82565-E2E8-4DBE-B0A5-2AB3746B18F7</gtr:id><gtr:title>Mechanistic insights into vascular calcification in CKD.</gtr:title><gtr:parentPublicationTitle>Journal of the American Society of Nephrology : JASN</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/bd1a1d34ee87797e6dcfe5a392859961"><gtr:id>bd1a1d34ee87797e6dcfe5a392859961</gtr:id><gtr:otherNames>Shroff R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1046-6673</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/61C1CE12-B3AA-4A47-917E-18FDE1A564A6"><gtr:id>61C1CE12-B3AA-4A47-917E-18FDE1A564A6</gtr:id><gtr:title>Diabetic Nephropathy: Perspective on Novel Molecular Mechanisms.</gtr:title><gtr:parentPublicationTitle>Trends in endocrinology and metabolism: TEM</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/397951267c5917353ff0577501f2a63d"><gtr:id>397951267c5917353ff0577501f2a63d</gtr:id><gtr:otherNames>Gnudi L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1043-2760</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/52110A6B-2547-4354-A3CF-2ED6171DB393"><gtr:id>52110A6B-2547-4354-A3CF-2ED6171DB393</gtr:id><gtr:title>HDL in children with CKD promotes endothelial dysfunction and an abnormal vascular phenotype.</gtr:title><gtr:parentPublicationTitle>Journal of the American Society of Nephrology : JASN</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/bd1a1d34ee87797e6dcfe5a392859961"><gtr:id>bd1a1d34ee87797e6dcfe5a392859961</gtr:id><gtr:otherNames>Shroff R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1046-6673</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/ECB4E828-7F16-49D5-B62C-73E7383146F1"><gtr:id>ECB4E828-7F16-49D5-B62C-73E7383146F1</gtr:id><gtr:title>Loss of endogenous thymosin ?4 accelerates glomerular disease.</gtr:title><gtr:parentPublicationTitle>Kidney international</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/85373a2da5384ab7e22d24df1461b0f3"><gtr:id>85373a2da5384ab7e22d24df1461b0f3</gtr:id><gtr:otherNames>Vasilopoulou E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0085-2538</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/05D7D6B8-0BC4-4BD2-9BDC-C8B058B10C39"><gtr:id>05D7D6B8-0BC4-4BD2-9BDC-C8B058B10C39</gtr:id><gtr:title>Vascular Endothelial Growth Factor C for Polycystic Kidney Diseases.</gtr:title><gtr:parentPublicationTitle>Journal of the American Society of Nephrology : JASN</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/b31418c203091e8945bc50b92174fbda"><gtr:id>b31418c203091e8945bc50b92174fbda</gtr:id><gtr:otherNames>Huang JL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1046-6673</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/8CEF37FD-5C80-4D9F-879E-6AA62901FE8B"><gtr:id>8CEF37FD-5C80-4D9F-879E-6AA62901FE8B</gtr:id><gtr:title>Albuminuria is associated with too few glomeruli and too much testosterone.</gtr:title><gtr:parentPublicationTitle>Kidney international</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/3545a93b5a4be2baaaefc96eef4da3a4"><gtr:id>3545a93b5a4be2baaaefc96eef4da3a4</gtr:id><gtr:otherNames>Long DA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0085-2538</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/B231A221-A127-4CA0-8CE8-420BDA3042D9"><gtr:id>B231A221-A127-4CA0-8CE8-420BDA3042D9</gtr:id><gtr:title>Planar cell polarity genes Celsr1 and Vangl2 are necessary for kidney growth, differentiation, and rostrocaudal patterning.</gtr:title><gtr:parentPublicationTitle>Kidney international</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/19ac368b3fd2c31caaff36f0b7a629af"><gtr:id>19ac368b3fd2c31caaff36f0b7a629af</gtr:id><gtr:otherNames>Brz?ska HL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0085-2538</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/3DFD91D6-2899-48EB-9CC1-77A1A12ABAB1"><gtr:id>3DFD91D6-2899-48EB-9CC1-77A1A12ABAB1</gtr:id><gtr:title>Vascular growth factors play critical roles in kidney glomeruli.</gtr:title><gtr:parentPublicationTitle>Clinical science (London, England : 1979)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/397951267c5917353ff0577501f2a63d"><gtr:id>397951267c5917353ff0577501f2a63d</gtr:id><gtr:otherNames>Gnudi L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0143-5221</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/4B0B9967-CCDD-4F01-A528-F55364C69505"><gtr:id>4B0B9967-CCDD-4F01-A528-F55364C69505</gtr:id><gtr:title>Planar cell polarity and the kidney.</gtr:title><gtr:parentPublicationTitle>Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/0da36c5e70660b223fa1b22d3238409d"><gtr:id>0da36c5e70660b223fa1b22d3238409d</gtr:id><gtr:otherNames>Papakrivopoulou E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0931-0509</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/FC2EBC86-4301-4ACB-B9F3-1FFAF152F50B"><gtr:id>FC2EBC86-4301-4ACB-B9F3-1FFAF152F50B</gtr:id><gtr:title>Circulating angiopoietin-2 is a marker for early cardiovascular disease in children on chronic dialysis.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/42950074035240bf79a7333ba3dadc2f"><gtr:id>42950074035240bf79a7333ba3dadc2f</gtr:id><gtr:otherNames>Shroff RC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/FB25797D-2602-4D62-B31E-5FE86B7E8CF1"><gtr:id>FB25797D-2602-4D62-B31E-5FE86B7E8CF1</gtr:id><gtr:title>The role of thymosin-?4 in kidney disease.</gtr:title><gtr:parentPublicationTitle>Expert opinion on biological therapy</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/85373a2da5384ab7e22d24df1461b0f3"><gtr:id>85373a2da5384ab7e22d24df1461b0f3</gtr:id><gtr:otherNames>Vasilopoulou E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1471-2598</gtr:issn></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">MR/J003638/1</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>2EEE0958-6BE1-4D16-B86B-5D954CD37219</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Renal and Urogenital</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>CF950C9A-DB16-4E23-8AEB-94548777BCA1</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>1.1  Normal biological development and functioning</gtr:text></gtr:researchActivity><gtr:researchActivity><gtr:id>1BF330A9-C7B5-49C5-B54B-CF4FAE6DF1D8</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>2.1  Biological and endogenous factors</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>